Staten Island University Hospital Prince’s Bay awardedPrimary Stroke Certification from The Joint Commission

Staten Island University Hospital (SIUH) Prince’s Bay has earned The Joint Commission’s Gold Seal of Approval® and the American Stroke Association’s Heart-Check mark for Primary Stroke Certification.
SIUH Prince’s Bay underwent a rigorous onsite review in August.  During the visit, a team of Joint Commission reviewers evaluated compliance with related certification standards including the use of evidence-based guidelines for stroke care, adoption of standardized performance measures, composition of the program’s interdisciplinary team, program’s mission and scope of services, stroke policies, EMS protocols, and imaging capabilities.
Joint Commission standards are developed in consultation with health care experts and providers, measurement experts and patients. The reviewers also conducted onsite observations and interviews.
“Primary Stroke Certification recognizes health care organizations committed to fostering continuous quality improvement in patient safety and quality of care,” says Mark Pelletier, RN, MS, chief operating officer, Accreditation and Certification Operations, and chief nursing executive, The Joint Commission. “We commend SIUH Princes’ Bay for using certification to reduce variation in its clinical processes and to strengthen its program structure and management framework for stroke patients.”
“We congratulate SIUH Prince’s Bay for this outstanding achievement,” says Nancy Brown, chief executive officer, the American Stroke Association. “This certification reflects its commitment to providing the highest quality of care for stroke patients.”
“SIUH Prince’s Bay has been the main hospital for the South Shore of Staten Island for many years,” said Yasir El-Sherif, director of the Stroke Services at SIUH. “Now with the Joint Commission certification we will be able to provide top quality care in Stroke to the residents of Staten Island. Our multidisciplinary team is composed of a rather large number of Staten Islanders who are dedicated to helping elevate Neuroscience care to their family, friends and fellow Staten Islanders by constantly driving safety, quality, and compassionate care.”
SIUH’s journey towards the Primary Stroke Certification ramped up two years ago with the creation of a core group and framework led by their stroke program. This team, comprised of multidisciplinary clinical providers and administrative leaders, focused on certification standards, clinical practice guidelines, process improvements, performance measures, and outcomes all while establishing a consistent approach to stroke care.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”